Novartis | NOVN

Stock Price
123.20
Daily Change
0.30 0.24%
Monthly
-2.53%
Yearly
26.62%
Q2 Forecast
116.14

EPS Reference Time Actual Consensus Previous
2025-10-28 FY2025Q3 2.04 1.58
2025-07-17 FY2025Q2 AM 2.42 1.97
2025-04-29 FY2025Q1 2.28 1.80
2025-01-31 FY2024Q4 1.98 1.82 1.53
2024-10-29 FY2024Q3 AM 1.58 1.74



Peers Price Chg Day Year Date
AbbVie 208.84 -6.14 -2.86% 3.57% Apr/02
Alcon AG 60.32 0.24 0.40% -23.06% Apr/02
Almirall 12.32 0.02 0.16% 27.34% Apr/02
Amgen 347.94 -5.34 -1.51% 12.29% Apr/02
Autolus Therapeutics Ltd 1.41 0.03 2.17% -6.62% Apr/02
AstraZeneca 15,316.00 294.00 1.96% 34.45% Apr/02
Bayer 39.70 -0.43 -1.06% 86.67% Apr/02
Biogen 177.34 -6.44 -3.50% 35.67% Apr/02
Bristol-Myers Squibb 59.60 -2.13 -3.45% 3.08% Apr/02
Fresenius Medical Care 38.67 0.08 0.21% -17.09% Apr/02

Indexes Price Day Year Date
CH20 12982 -9.28 -0.07% 5.72% Apr/02
EU600 597 0.01 0.002% 20.21% Apr/03

Novartis traded at 123.20 this Thursday April 2nd, increasing 0.30 or 0.24 percent since the previous trading session. Looking back, over the last four weeks, Novartis gained 2.53 percent. Over the last 12 months, its price rose by 26.62 percent. Looking ahead, we forecast Novartis to be priced at 116.14 by the end of this quarter and at 107.58 in one year, according to Trading Economics global macro models projections and analysts expectations.

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.



News Stream
Novartis Stock Price Hits All-time High
Novartis shares increased to an all-time high of 117.46 CHF. Over the past 4 weeks, Novartis gained 5.76%, and in the last 12 months, it increased 20.06%.
2026-02-02
Novartis Stock Price Hits All-time High
Novartis shares increased to an all-time high of 116.82 CHF. Over the past 4 weeks, Novartis gained 6.24%, and in the last 12 months, it increased 26.31%.
2026-01-27
Novartis Stock Price Hits All-time High
Novartis shares increased to an all-time high of 108.54 CHF. Over the past 4 weeks, Novartis gained 1.38%, and in the last 12 months, it increased 21.86%.
2025-12-16